This study aimed to investigate the efficacies and complications associated with the 7F catheter inserted in patients with pneumothorax in the emergency room and to compare the results for primary and secondary pneumothorax. From June 2006 to May 2008, 200 patients with primary or secondary pneumothorax treated with a 7F catheter were enrolled. The primary endpoint was the immediate success rate. Success with the 7F catheter was defined as complete or nearly complete lung expansion following insertion without the need for a conventional chest tube or surgical treatment. One hundred fifty-four patients were diagnosed with primary pneumothorax, 38 patients with secondary pneumothorax, and eight patients with iatrogenic pneumothorax. Treatment for 48 of the 200 patients (24.0%) failed; 30 patients were given a conventional chest tube and 18 patients had surgical resections without a conventional chest tube. The failure group included 26 patients (16.9%) with primary, 20 patients (52.6%) with secondary, and two patients (25%) with iatrogenic pneumothorax. The failure rate of patients with secondary pneumothorax was significantly higher than that of patients with primary pneumothorax (P-0.05). We can confirm that the 7F catheter is an effective approach to the treatment of primary pneumothorax, including first, recurrent, and postoperative pneumothorax.
Introduction
Closed thoracostomy is indicated in many clinical situations, such as pneumothorax, pleural effusion, or hemothorax. The large-bore thoracic catheter (LBTC) has traditionally been used for drainage of the thoracic cavities; however, there is a global trend toward increased use of the small-bore thoracic catheter (SBTC). Closed thoracostomy using the LBTC is associated with significant discomfort and pain at the time of insertion, during drainage, and removal of drains. In contrast, the SBTC -10 French (F), is easy to insert and essentially painless; therefore, the British Thoracic Society now recommends the SBTC (10-14F) for the treatment of primary spontaneous pneumothorax (PSP) and malignant effusion w1, 2x. However, in secondary spontaneous pneumothorax (SSP), there is lack of widely accepted management guidelines. A variety of SBTC and insertion kits are available, and to date we have regularly used a 7F catheter, which was originally designed for central venous catheterization, as an initial management of pneumothorax in the emergency room (ER). Therefore, this study aimed to investigate the efficacies and complications associated with 7F catheter inserted in patients with pneumothorax in the ER and to compare the results in cases of primary and secondary pneumothorax. . E-mail address: bay@knu.ac.kr (E.B. Lee).
Materials and methods

Patients
From June 2006 to May 2008, the data of patients with pneumothorax in whom the 7F catheter were inserted in the ER regardless of the causes were retrospectively collected and reviewed.
Treatment protocol
First, an SBTC was inserted regardless of the causes of pneumothorax in the ER. The inserted 7F catheter was connected via a three-way valve to a 50-ml syringe and air was manually aspirated until a resistance was felt, and then air was no longer aspirated. If the lung was not fully expanded in a chest X-ray (CXR) check, the 7F catheter was connected to water-sealed bottles. Once there was no longer air leakage from the chest tube system and the lung had reached full expansion, as revealed by CXR, the 7F catheter was removed. If there was a persistent air leak and persistent dead space for more than three days or there were complications, such as subcutaneous emphysema, frequent kinking, or dislodgement, an LBTC was inserted after removal of the SBTC, or definitive corrective surgery was undertaken. 
Catheter insertion
After skin disinfection and field preparation, a needle was introduced into the intercostal space after local anesthesia. After the needle entered the pleural space, the needle was directed apically and the catheter guided by wire was advanced into the pleural space. The catheter was fixed to the skin using sterile adhesive tape.
End point
The primary endpoint was the immediate success rate. Success for the 7F catheter was defined as complete or nearly complete lung expansion following insertion without the need for an LBTC or surgical treatment. Failure was defined as the need for an LBTC or surgical treatment for ineffective drainage or the management of complications of the 7F catheter. However, patients who were treated successfully by SBTC but operated on according to protocol were not considered to be part of the failure group. The secondary endpoint was safety and clinical outcomes of the technique.
Statistical analysis
Demographic and descriptive data are given as means" standard deviation (S.D.). The categorical variables were compared using a x or Fisher's exact test. Data were 2 analyzed using statistical software (SPSS statistical software for Windows, Chicago, IL, USA; statistical significance -0.05).
Results
Two hundred patients, including 172 men and 28 women, were enrolled in this study. The mean age was 37.2 years old (range 14-88 years old) and 96 patients (48%) were smokers. The iatrogenic pneumothorax included five patients who had percutaneous needle lung biopsy and three patients who had central line catheterization ( Table  1) . The size of pneumothorax on the initial CXR checked ranged from 22% to 95%, with a mean"S.D. of 58.4"21.1%. Of the samples, the catheter in 89 patients was in the upward position, downward in 66 patients, and horizontal in 45 patients ( Table 2 ). There were no mortalities and no major complications (bleeding, empyemayinfection, inadequate position, pulmonary laceration). Most minor complications (ns24, 12%) were subcutaneous emphysema in 18 patients (9%), frequent kinking in three patients (1.5%), dislodgement in two patients (1%), and re-expansion pulmonary edema in one patient (0.5%).
Treatment for 48 of the 200 patients (24.0%) failed; 30 patients had an LBTC and 18 patients had surgical resection without an LBTC. Thirty patients in whom a 7F was replaced with an LBTC had persistent air leakage and persistent dead space or subsequent subcutaneous emphysema. Of 30 patients, eight patients had PSP, 20 patients had SSP, and two patients had iatrogenic pneumothorax. Two of eight patients (25%) with PSP and six of 20 patients (30%) in whom the SBTC was replaced with an LBTC were additionally managed with surgical resection. Of 18 patients who underwent surgical treatment without LBTC replacement, 16 patients with PSP met the criteria for surgery, and two patients had primary spontaneous hemopneumothorax. The failure group included 26 patients (16.9%) with PSP, 20 patients (52.6%) with SSP, and two patients (25%) with iatrogenic pneumothorax. The proportion of patients with SSP was significantly higher than that of patients with PSP (P-0.05). Regarding the position of the 7F catheter's tip, the downward position was more common in the failure group and showed borderline statistical significance (Ps0.06). The mean duration of use of the 7F catheter and mean hospitalization stay in the success group were 2.8 and 3.5 days, respectively, while in the failure group, the mean duration of LBTC use and mean hospitalization stay were 10.1 and 13.7 days, respectively (Table 3) .
Discussion
This study focused on the efficacy of SBTC for management of primary and secondary pneumothorax. Since Sargent and Turner described the successful drainage of more than 20 cases of PSP with the use of a 9F Teflon catheter w3x, many studies have shown that PSP can be treated well with various SBTCs w4-6x. Among them, Liu et al. reported comparable results of pigtail tube drainage with a conventional chest tube in the treatment of PSP and concluded that the pigtail tube drainage system can be considered the treatment of choice for PSP w6x. The SBTC has been shown to be less painful and better tolerated than larger ones when assessed by a VAS scoring system. Based on a randomized prospective study, Terzi et al. reported that drain-related pain was significantly less for patients with a SBTC (19F) compared to a standard chest tube (28F) at rest, while coughing, and at the time of removal w7x. In addition to pain, the cosmetic aspect is another of the advantages, especially for female patients. The skin incisions to place the SBTC are smaller than those used for the LBTC, and thus it is possible to insert the SBTC in the thorax out of range of vision, such as axilla or below the breast. In inserting the conventional LBTC, the physician must bluntly dissect the intercostal tissues, which requires significant force and may cause inadvertent damage to the chest wall and the underlying organs. However, even a less experienced physician can easily insert the SBTC without trouble or assistance. The complication rates quoted for an LBTC vary between 5% and 35%, and include the pain related to drainage, empyema, improper tube positioning, post-tube removal complications, and direct injuries to the lung w8-10x. In addition to the same complications as an LBTC, an SBTC also has its own complications. As the thoracic catheter becomes smaller and more flexible, a change of location, blockage, or dislodgement of the catheter are more likely to occur w11, 12x. There may be concerns about the effectiveness of the SBTC for the management of pneumothorax if the direction of the tip does not face apically. In this study, about 55.5% of the thoracic catheters had their tips facing below or toward the mediastinum; however, there was no difference in the time taken for the lung to fully expand nor in the success rate. Another problem is blockage of the SBTC, particularly those inserted due to empyema or hemothorax w11x. However, blockage is not a common complication in the management of pneumothorax. This study included six patients with hemopneumothorax, and the presence of hemothorax was not a significant factor in the failure rate. That might be because of the small number of patients. Although about 6% of dislodgement of drains have previously been reported w11x, we had only two cases of dislodged drains. In our opinion, the main cause of dislodgement might depend not on methods of fixation but the weight of the connected bottle. If it were connected to a conventional water sealed bottle, the drain could become dislodged or kinked. Instead of a conventional chest tube bottle, we used the Heimlich valve, which is lighter, or a small-sized water sealed bottle that was made by our department. In our study, the results from use of the SBTC for PSP showed an 83.1% success rate, which is comparable with other studies w6x. Its high success rate may be related with our protocol. Because we have used both SBTC and aspiration through the tube simultaneously, the additive effects could explain the lower failure rate. However, the success rate of the SBTC was disappointing in the management of SSP. As SSP occurs in patients with underlying pulmonary disease, persistent air leaks and incomplete expansion of the lung are more common than in PSP after closed thoracostomy. Several options are available for the management of SSP; there is a lack of widely accepted management guidelines. Regarding the adequate tube size, there is no evidence that the efficacy of the LBTC is greater than that of the SBTC w5x. Tsai et al. reported a 72.5% success rate using SBTC, which is a rate similar to that of a conventional chest tube as an initial treatment of SSP, and concluded that the pigtail catheter appears to be a safe and promising technique w5x. However, the 47.4% success rate in this study is lower than other studies on the management of SSP. The following reasons can be attributed to the high failure rate in the current study: as a rule, as our physicians or surgeons have thought that SSP was managed with a conventional chest tube, thus there were more cases in which an SBTC was replaced with an LBTC as soon as an unexpanded lung or subcutaneous emphysema was detected. That was the weakness of our study. Because this study was not conducted by prospective randomized methods, there was no definite protocol for the SBTC for SSP; therefore, a selection bias was inevitably present. Further studies that include a larger number of patients with SSP and have well planned protocols are required to more thoroughly investigate the effectiveness of SBTC.
In conclusion, we can confirm that using the SBTC is an effective approach for the treatment of PSP including first PSP, recurrent PSP, and postoperative pneumothorax. We also suggest the potential of the SBTC for the management of SSP.
